Strategic Brand Planning: Winning by Resource Optimization

Our client was a global biopharmaceutical company with a market-leading brand more than 20 years’ old. It came under intense pricing pressure due to generic entries from companies known to play primarily on price.

Mature Brand Planning: Specialty Product Late Life Cycle Management Strategy

Our global pharmaceutical client had a product whose patent was expiring within a year. The client wanted to understand the potential impact of generic competition on its brand in key revenue markets. Prescient was engaged to develop tactics to defend market share in these markets by:

Net Present Value: Assessing Opportunities for Indication Expansion

Our client, a European specialty pharmaceutical company, was considering an expansion of indications within its target therapeutic group via licensing and acquiring products that were in clinical development, soon-to-be-launched or already marketed.

Commercial Opportunity Assessment: Revenue Forecasting for a Specialty Product

Our global pharmaceutical client was developing a suite of biosimilars that it intended to commercialize in several Latin American countries. The client engaged Prescient to investigate regulatory, pricing, reimbursement and purchasing models to generate volume and revenue forecasts (through 2025) and quantify the market opportunity for the biosimilars in these countries.

Stakeholder Engagement Strategies: Providing a Deeper Understanding of Potential Customers

Our client, a global pharmaceutical company, was in the process of strengthening the vision for its future product portfolio. The marketing team needed to identify potential high-prescribing customers to develop a marketing campaign that would support its strategy for optimally co-positioning future therapies. There were several unknowns about the potential license for our client’s product, so Prescient was engaged to develop strong, focused positioning concepts that would resonate with the emotional needs of target customers.

1 2 3 5